The Filing Desk

CytoSorbents vs Utah Medical Products

CytoSorbents CTSO · Utah Medical Products UTMD · Health Care Equipment

Utah Medical Products reported revenue of $38 million in fiscal 2025, about the same as CytoSorbents' $37 million in fiscal 2025. CytoSorbents' revenue grew 4.1% in its latest year, and Utah Medical Products' fell 5.8%. CytoSorbents had an operating margin of -39.8%, against 29.6% at Utah Medical Products. Free cash flow was −$13 million at CytoSorbents and $14 million at Utah Medical Products.

Side by side

CytoSorbentsUtah Medical Products
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$37M$38M
Revenue growth4.1%−5.8%
Revenue growth a year, last 5 years−2.0%−1.8%
Gross margin71.5%57.1%
Operating margin−39.8%29.6%
Net margin−22.1%29.3%
Free cash flow−$13M$14M
Free cash flow margin−33.8%37.2%
Return on capital—26.8%
Net debt to EBITDA—−6.0x
Dividends and buybacks$0M$12M
Change in diluted share count14.3%−7.5%
Last close$5.13$70.96
P/E at the last close—21.2×
Insider trades, last 12 monthsbought $269,332, sold $0—
Piotroski F-score—6 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
CytoSorbentsUtah Medical Products
Operating margin
Percent of revenue
CytoSorbentsUtah Medical Products
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CytoSorbentsUtah Medical Products

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the CytoSorbents and Utah Medical Products pages.